Scotia Capital’s Organigram Holdings OGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,862
Closed -$21.4K 878
2024
Q2
$21.4K Sell
13,862
-774
-5% -$1.41K ﹤0.01% 816
2024
Q1
$31.2K Buy
14,636
+637
+5% +$1.23K ﹤0.01% 816
2023
Q4
$18.2K Buy
13,999
+1,278
+10% +$1.57K ﹤0.01% 785
2023
Q3
$16.6K Sell
12,721
-706
-5% -$1.06K ﹤0.01% 763
2023
Q2
$20.3K Sell
13,427
-34
-0.3% -$66 ﹤0.01% 775
2023
Q1
$34.3K Sell
13,461
-519
-4% -$1.65K ﹤0.01% 766
2022
Q4
$43.8K Sell
13,980
-2,263
-14% -$8.51K ﹤0.01% 760
2022
Q3
$57K Sell
16,243
-1,675
-9% -$7.01K ﹤0.01% 752
2022
Q2
$65K Sell
17,918
-2,171
-11% -$11.1K ﹤0.01% 772
2022
Q1
$134K Buy
20,089
+2,518
+14% +$15.5K ﹤0.01% 824
2021
Q4
$124K Buy
17,571
+3,682
+27% +$31.3K ﹤0.01% 828
2021
Q3
$128K Buy
13,889
+224
+2% +$2.29K ﹤0.01% 820
2021
Q2
$156K Buy
13,665
+2,532
+23% +$28.8K ﹤0.01% 785
2021
Q1
$154K Sell
11,133
-14,442
-56% -$167K ﹤0.01% 756
2020
Q4
$136K Buy
25,575
+67
+0.3% +$344 ﹤0.01% 720
2020
Q3
$107K Sell
25,508
-917
-3% -$4.78K ﹤0.01% 675
2020
Q2
$169K Sell
26,425
-1,614
-6% -$10.9K ﹤0.01% 587
2020
Q1
$223K Buy
28,039
+1,011
+4% +$9.18K ﹤0.01% 553
2019
Q4
$264K Buy
27,028
+4,931
+22% +$58.2K ﹤0.01% 646
2019
Q3
$303K Buy
22,097
+4,656
+27% +$97.9K ﹤0.01% 604
2019
Q2
$449K Buy
+17,441
New +$484K 0.01% 536

Other funds holding OGI

Scotia Capital's OGI Position: Q3 2024 in Review

Scotia Capital sold out of Organigram Holdings (OGI) in Q3 2024, closing a stake of 13,862 shares — an estimated $21.4K sold.

Scotia Capital first reported a position in OGI in Q2 2019 and held it in 21 quarters. The position peaked at $449K in Q2 2019. 71 funds tracked by Wall St. Rank hold OGI as of Q3 2024.

  • Scotia Capital reported no remaining Organigram Holdings position as of Q3 2024 after selling out during the quarter.
  • Scotia Capital sold 13,862 Organigram Holdings shares in Q3 2024, an estimated $21.4K.
  • Scotia Capital first reported a position in Organigram Holdings in Q2 2019 and held it in 21 quarters.
  • Scotia Capital's Organigram Holdings position peaked at $449K in Q2 2019.
  • 71 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2024.

Based on Scotia Capital's 13F filing for Q3 2024, filed 13 Nov 2024.